Investor Update

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer

about 2 hours ago

Approval based on Phase III ALINA study showing Alecensa reduced the risk...

Reminder: Invitation to Roche’s First Quarter Sales 2024 Presentation

2 days ago

 Roche will publish its Sales Results for the 1st Quarter 2024 prior...

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study

4 days ago

Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall...

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis

8 days ago

The Elecsys® pTau217 plasma biomarker test is being developed as part of...

Invitation: Roche Diagnostics Investor Day 2024

9 days ago

  The Roche Investor Relations team would like to invite you to the...

Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran added to standard of care antihypertensives in patients with inadequately controlled hypertension

12 days ago

The KARDIA-2 study met its primary endpoint demonstrating additive, placebo-adjusted systolic blood...

Chugai: Piasky (crovalimab) for Paroxysmal Nocturnal Hemoglobinuria approved in Japan

24 days ago

Roche receives FDA approval for the first molecular test to screen for malaria in blood donors

24 days ago

Invitation to Roche’s First Quarter Sales 2024 Presentation

28 days ago

  Roche will publish its Sales Results for the 1st Quarter 2024 prior...

Alnylam to webcast investor event to discuss results from KARDIA-2 phase 2 study of zilebesiran at American College of Cardiology Scientific Session

30 days ago

Dear Investor, Please find below link to a press release from our...

Roche enters into a definitive agreement with Lonza, which will acquire the Genentech manufacturing facility in Vacaville, California, USA

about 1 month ago

Basel, 20 March 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...

Roche Annual General Meeting 2024

about 1 month ago

All proposals of the Board of Directors approvedSeverin Schwan re-elected as Chairman...